Evidence map›Paper›PMID 32588943›Full record

ReviewDiabetes/metabolism research and reviews2021

Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19).

Yue Zhou, Jingwei Chi, Wenshan Lv, Yangang Wang

Registry-linked trialAbstract readReview
In one paragraph

Review in Diabetes/metabolism research and reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05950256 (Physiological Impact of Surgical Mask and N95 Mask on Obese Operating Room Staff:A Randomized-Controlled Cross-Over Trial), which is not on this map. Cited by 283 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
283citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05950256 nacompletednot on this mapstarted 2023, after this paper: background citation

Physiological Impact of Surgical Mask and N95 Mask on Obese Operating Room Staff:A Randomized-Controlled Cross-Over Trial

TypeinterventionalSponsorQilu Hospital of Shandong UniversityRan2023 to 2024Enrolled20ConditionsObesityArmsN95 mask and surgical mask
3 · Its place in the literature

Who cites it

283 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Observational
  18. Review
  19. Article
  20. Article

223 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yue ZhouDepartment of Endocrinology, Affiliated Hospital of Medical College Qingdao University, Qingdao, China.
Jingwei ChiDepartment of Endocrinology, Affiliated Hospital of Medical College Qingdao University, Qingdao, China.
Wenshan LvDepartment of Endocrinology, Affiliated Hospital of Medical College Qingdao University, Qingdao, China.
Yangang WangDepartment of Endocrinology, Affiliated Hospital of Medical College Qingdao University, Qingdao, China.ORCID 0000-0001-6597-420X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The outbreak of the coronavirus disease 2019 (Covid-19) has become an evolving worldwide health crisis. With the rising prevalence of obesity and diabetes has come an increasing awareness of their impacts on infectious diseases, including increased risk for various infections, post-infection complications and mortality from critical infections. Although epidemiological and clinical characteristics of Covid-19 have been constantly reported, no article has systematically illustrated the role of obesity and diabetes in Covid-19, or how Covid-19 affects obesity and diabetes, or special treatment in these at-risk populations. Here, we present a synthesis of the recent advances in our understanding of the relationships between obesity, diabetes and Covid-19 along with the underlying mechanisms, and provide special treatment guidance for these at-risk populations.

Indexed as

ComorbidityCOVID-19Critical IllnessDiabetes ComplicationsDiabetes MellitusHumansObesityPandemicsPrevalencePrognosisRisk FactorsSARS-CoV-2Severity of Illness IndexCovid-19diabetes mellitusobesitysevere coronavirus disease 2019

Identifiers

PMID32588943
PMCPMC7361201

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.